Literature DB >> 12906906

Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography.

S Sentenac1, C Fernandez, A Thuillier, P Lechat, G Aymard.   

Abstract

A new high-performance liquid chromatography assay was developed for the determination of tenofovir, a nucleotide analogue, in plasma. A solid-liquid extraction procedure was coupled with a reversed-phase HPLC system. The system requires a mobile phase containing Na(2)HPO(4) buffer, tetrabutylammonium hydrogen sulfate and acetonitrile for different elution through a C(18) column with UV detection. The method proved to be accurate, precise and linear between 10 and 4000 ng/ml. The method was applied to determine trough levels of tenofovir in 11 HIV-infected patients with virologic failure under multiple antiretroviral therapy. This method was also successfully applied to a pharmacokinetic study in an HIV infected patient with renal failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906906     DOI: 10.1016/s1570-0232(03)00333-7

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  12 in total

1.  Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine.

Authors:  Vivek Agrahari; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2012-01-04       Impact factor: 3.246

2.  Direct and real-time quantification of tenofovir release from ph-sensitive microparticles into simulated biological fluids using (1)h nuclear magnetic resonance.

Authors:  Chi Zhang; Tao Zhang; Nathan A Oyler; Bi-Botti C Youan
Journal:  J Pharm Sci       Date:  2014-04       Impact factor: 3.534

3.  Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.

Authors:  Rajeth Koneru; M Foster Olive; William R Tyor
Journal:  J Neurovirol       Date:  2014-01-11       Impact factor: 2.643

4.  Development of an LC-MS method for measuring TNF in human vaginal tissue.

Authors:  S O Choi; N Rezk; J S Kim; A D M Kashuba
Journal:  J Chromatogr Sci       Date:  2010-03       Impact factor: 1.618

5.  Evaluation of degradation kinetics and physicochemical stability of tenofovir.

Authors:  Vivek Agrahari; Sandeep Putty; Christiane Mathes; James B Murowchick; Bi-Botti C Youan
Journal:  Drug Test Anal       Date:  2014-05-12       Impact factor: 3.345

6.  Simultaneous spectrophotometric estimation of tenofovir disoproxil fumarate and Lamivudine in three component tablet formulation containing efavirenz.

Authors:  R Sharma; K Mehta
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

7.  Stress studies of tenofovir disoproxil fumarate by HPTLC in bulk drug and pharmaceutical formulation.

Authors:  Shweta Havele; Sunil R Dhaneshwar
Journal:  ScientificWorldJournal       Date:  2012-04-19

8.  Establishment of HK-2 Cells as a Relevant Model to Study Tenofovir-Induced Cytotoxicity.

Authors:  Rachel A Murphy; Reagan M Stafford; Brooke A Petrasovits; Megann A Boone; Monica A Valentovic
Journal:  Int J Mol Sci       Date:  2017-03-01       Impact factor: 5.923

9.  Spectrophotometric simultaneous determination of Tenofovir disoproxil fumarate and Emtricitabine in combined tablet dosage form by ratio derivative, first order derivative and absorbance corrected methods and its application to dissolution study.

Authors:  Vishnu P Choudhari; Snehal Ingale; Sacchidanand R Gite; Dipali D Tajane; Vikram G Modak; Archana Ambekar
Journal:  Pharm Methods       Date:  2011-01

10.  RP-HPLC method for simultaneous estimation of tenofovir disoproxil fumarate, lamivudine, and efavirenz in combined tablet dosage form.

Authors:  Dhara S Bhavsar; Bhavini N Patel; Chhaganbhai N Patel
Journal:  Pharm Methods       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.